Stay informed with the latest updates for the inheritable blood disorders community.

NBDF & Community
2020 NYC Half Marathon Cancelled
2020 NYC Half Marathon Cancelled
COVID-19
NHF Office Response to COVID-19
NHF Office Response to COVID-19
NBDF & Community
Takeda Responds to HFA-NHF Letter on VONVENDI Recall
Takeda Responds to HFA-NHF Letter on VONVENDI Recall
COVID-19
NHF Letter to the Community on COVID-19
NHF Letter to the Community on COVID-19
Industry
Genentech Provides Updates on Hemlibra Product Particles
Medexus Acquires XINITY® from Aptevo
NBDF & Community
MASAC Letter to the Community Regarding the Coronavirus Disease 2019
MASAC Letter to the Community Regarding the Coronavirus Disease 2019
Advocacy & Legislative
Bleeding Disorders Community Advocates in Washington, DC
Bleeding Disorders Community Advocates in Washington, DC
NBDF & Community
Community Statement from Genentech on Hemlibra supply amid 2019-nCoV
Community Statement from Genentech on Hemlibra supply amid 2019-nCoV
Advocacy & Legislative
NHF Urges Congressional Action on The Hemophilia SNF Access Act
NHF Urges Congressional Action on The Hemophilia SNF Access Act
NBDF & Community
Joint Statement on Recall of VONVENDI Lots
Joint Statement on Recall of VONVENDI Lots
NBDF & Community
Takeda announced a pharmacy-level recall of two lots of VONVENDI
Takeda announced a pharmacy-level recall of two lots of VONVENDI
Medical
Partners in Bleeding Disorders Education Program Launches Revised Module
Partners in Bleeding Disorders Education Program Launches Revised Module
NBDF & Community
Letter to the NHF Community
Letter to Our Community
Medical
NHF Announces 2020 Physical Therapy Excellence Fellowship Award
NHF Announces 2020 Physical Therapy Excellence Fellowship Award
Medical
Emergency Department Guidelines Now Available in Multiple Formats
Emergency Department Guidelines Now Available in Multiple Formats